MedPath

CAPOGROSSO MARCO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb

Not Applicable
Recruiting
Conditions
Spinal Muscular Atrophy Type 3
Spinal Muscular Atrophy Type II
Spinal Muscular Atrophy 4
SMA
Spinal Muscular Atrophy
First Posted Date
2024-03-08
Last Posted Date
2024-08-14
Lead Sponsor
Marco Capogrosso
Target Recruit Count
20
Registration Number
NCT06300996
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Spinal Cord Stimulation in Spinal Muscular Atrophy

Not Applicable
Active, not recruiting
Conditions
Spinal Muscular Atrophy Type 3
Spinal Muscular Atrophy Type 4
First Posted Date
2022-06-24
Last Posted Date
2025-05-16
Lead Sponsor
Marco Capogrosso
Target Recruit Count
3
Registration Number
NCT05430113
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.